BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng SY, Li HX, Xu RC, Miao WT, Dai MY, Ding ST, Liu HD. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 2021;69:101347. [PMID: 33905953 DOI: 10.1016/j.arr.2021.101347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu M, Wang S, Hai W, Lu X, Li P. Development of a H(2)S-responsive NIR Fluorescent Probe for H(2)S Detection and H(2)S Releasing Monitoring From Prodrug. J Fluoresc 2023. [PMID: 36867290 DOI: 10.1007/s10895-023-03187-2] [Reference Citation Analysis]
2 Shi J, Wang Y, Chen D, Xu X, Li W, Li K, He J, Su W, Luo Q. The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease. Appl Microbiol Biotechnol 2023;107:1917-29. [PMID: 36795141 DOI: 10.1007/s00253-023-12410-w] [Reference Citation Analysis]
3 Kumari S, Taliyan R, Dubey SK. Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson's Disease. ACS Chem Neurosci 2023;14:590-602. [PMID: 36724408 DOI: 10.1021/acschemneuro.2c00730] [Reference Citation Analysis]
4 Guo TT, Zhang Z, Sun Y, Zhu RY, Wang FX, Ma LJ, Jiang L, Liu HD. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease. Nutrients 2023;15. [PMID: 36839287 DOI: 10.3390/nu15040930] [Reference Citation Analysis]
5 Nie S, Wang J, Deng Y, Ye Z, Ge Y. Inflammatory microbes and genes as potential biomarkers of Parkinson's disease. NPJ Biofilms Microbiomes 2022;8:101. [PMID: 36564391 DOI: 10.1038/s41522-022-00367-z] [Reference Citation Analysis]
6 Bi M, Feng L, He J, Liu C, Wang Y, Jiang H, Liu SJ. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance. Ageing Res Rev 2022;82:101759. [PMID: 36243356 DOI: 10.1016/j.arr.2022.101759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xi X, Han L. Exploring the relationship between novel Coronavirus pneumonia and Parkinson's disease. Medicine (Baltimore) 2022;101:e31813. [PMID: 36401405 DOI: 10.1097/MD.0000000000031813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang K, Zhang C, Zhang B, Li G, Shi G, Cai Q, Huang M. Gut dysfunction may be the source of pathological aggregation of alpha-synuclein in the central nervous system through Paraquat exposure in mice. Ecotoxicology and Environmental Safety 2022;246:114152. [DOI: 10.1016/j.ecoenv.2022.114152] [Reference Citation Analysis]
9 Xu RC, Miao WT, Xu JY, Xu WX, Liu MR, Ding ST, Jian YX, Lei YH, Yan N, Liu HD. Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice. Nutrients 2022;14:4163. [PMID: 36235813 DOI: 10.3390/nu14194163] [Reference Citation Analysis]
10 Liu Q, Qi H, Duan S, Xu Y, Zhang H. Frontiers and future perspectives of neuroimmunology. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.10.002] [Reference Citation Analysis]
11 D’argenio V, Veneruso I, Gong C, Cecarini V, Bonfili L, Eleuteri AM. Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s Disease. Genes 2022;13:1564. [DOI: 10.3390/genes13091564] [Reference Citation Analysis]
12 Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. Aging, testosterone, and neuroplasticity: friend or foe? Rev Neurosci 2022. [PMID: 36017670 DOI: 10.1515/revneuro-2022-0033] [Reference Citation Analysis]
13 Fehér J, Élő Á, István L, Nagy ZZ, Radák Z, Scuderi G, Artico M, Kovács I. Microbiota mitochondria disorders as hubs for early age-related macular degeneration. Geroscience 2022;44:2623-53. [PMID: 35978068 DOI: 10.1007/s11357-022-00620-5] [Reference Citation Analysis]
14 Zeng J, Wang X, Pan F, Mao Z. The relationship between Parkinson’s disease and gastrointestinal diseases. Front Aging Neurosci 2022;14:955919. [DOI: 10.3389/fnagi.2022.955919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Eicher TP, Mohajeri MH. Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases. Nutrients 2022;14:2661. [DOI: 10.3390/nu14132661] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
16 Wu H, Wei J, Zhao X, Liu Y, Chen Z, Wei K, Lu J, Chen W, Jiang M, Li S, Chen T. Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP ‐1 and modulating gut microbiota. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10351] [Reference Citation Analysis]
17 Ma H, Li X, Yang H, Qiu Y, Xiao W. The Pathology and Physiology of Ileostomy. Front Nutr 2022;9:842198. [DOI: 10.3389/fnut.2022.842198] [Reference Citation Analysis]
18 Chen P, Zhang J, Wang C, Chai YH, Wu AG, Huang NY, Wang L. The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine. Phytomedicine 2022;100:154044. [PMID: 35338993 DOI: 10.1016/j.phymed.2022.154044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Woodall CA, McGeoch LJ, Hay AD, Hammond A. Respiratory tract infections and gut microbiome modifications: A systematic review. PLoS One 2022;17:e0262057. [PMID: 35025938 DOI: 10.1371/journal.pone.0262057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Linard M, Ravier A, Mougué L, Grgurina I, Boutillier AL, Foubert-Samier A, Blanc F, Helmer C. Infectious Agents as Potential Drivers of α-Synucleinopathies. Mov Disord 2022. [PMID: 35040520 DOI: 10.1002/mds.28925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study. J Clin Med 2021;10:5698. [PMID: 34884399 DOI: 10.3390/jcm10235698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]